CSI Market
Sign In | Register

Antares Pharma Inc (ATRS) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ATRS quarterly Cash Flow →
The table below presents a historical view of Antares Pharma Inc's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2021)
12 Months 		(Dec 31 2020) (Dec 31 2019) (Dec 31 2018) (Dec 31 2017)
Operating Activities
Income60.23
Depreciation & amortization3.90
Amortization of Other Assets0.00
Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories2.75
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total-38.59
Share-based Compensation8.02
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Increase Decrease In Inventory Reserve0.15
Increase Decrease In Contract With Customer Liability0.48
Income taxes0.67
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-14.48
Increase (Decrease) in Accounts Payable2.19
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities11.60
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-1.06
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.76
Discontinued operations0.00
Net Cash flow from Operating Activities36.62
Investing Activities
Capital Expenditures-20.43
Sale of Capital Items17.83
Proceeds from Sale, Maturity and Collection of Short-term Investments0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments-1.25
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-3.85
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-2.33
Long-term debt - borrowings20.00
Long-term debt - repayments-40.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock5.18
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-2.84
Proceeds From Exercise Of Warrants And Stock Options-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-19.99
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow34.01
Total Cash Flow12.78
4 historic quarters locked

Sign in to unlock the full Antares Pharma Inc cash flow history.

Sign In Create Free Account

About Antares Pharma Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001016169-22-000044

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License